RTW INVESTMENTS LP 13D/13G Filings for SAB Biotherapeutics, Inc. (SABS)

RTW INVESTMENTS LP 13D and 13G filings for SAB Biotherapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-14
07:02 am
Purchase
2023-12-3113GSAB Biotherapeutics, Inc.
SABS
RTW INVESTMENTS LP9,220,672
9.990%
9,220,672increase
(New Position)
Filing